Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 46 entries
Sorted by: Best Match Show Resources per page
[Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Serrano FJ, Muñoz RM, Vidal SS, Morán FG, García CB, Aznar AB.
PMID: 10878537
Rev Esp Quimioter. 2000 Mar;13(1):44-50.

The susceptibility to ciprofloxacin of 7288 Escherichia coli clinical isolates from 5667 patients was determined over a 4-year period (1995-1998). Information about the patients' age, sex, specimen type, date, origin and susceptibility to Escherichia coli isolates was studied, and...

Cite
Serrano FJ, Muñoz RM, Vidal SS, et al. Aspectos epidemiológicos de la resistenciade Escherichia coli a ciprofloxacinoen un hospital general. [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital]. Rev Esp Quimioter. 2000;13(1):44-50
Serrano, F. J., Muñoz, R. M., Vidal, S. S., Morán, F. G., García, C. B., & Aznar, A. B. (2000). Aspectos epidemiológicos de la resistenciade Escherichia coli a ciprofloxacinoen un hospital general. [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 13(1), 44-50.
Serrano, et al. "Aspectos epidemiológicos de la resistenciade Escherichia coli a ciprofloxacinoen un hospital general." [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia vol. 13,1 (2000): 44-50.
Serrano FJ, Muñoz RM, Vidal SS, Morán FG, García CB, Aznar AB. Aspectos epidemiológicos de la resistenciade Escherichia coli a ciprofloxacinoen un hospital general. [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital]. Rev Esp Quimioter. 2000 Mar;13(1):44-50. Spanish. PMID: 10878537.
Copy Download .nbib Format: NLM
Controlled release systems based on poly(lactic acid). An in vitro and in vivo study.

Journal of materials science. Materials in medicine

Andreopoulos AG, Hatzi EC, Doxastakis M.
PMID: 15348021
J Mater Sci Mater Med. 2000 Jun;11(6):393-7. doi: 10.1023/a:1008990109419.

A new biodegradable delivery system based on poly(lactic acid) has been formulated, with potential applications in sustained antibiotic release against bone infection. The in vitro release of a new quinolone (pefloxacin) from low molecular weight poly(D,L-lactic acid) Mw =...

Cite
Andreopoulos AG, Hatzi EC, Doxastakis M. Controlled release systems based on poly(lactic acid). An in vitro and in vivo study. J Mater Sci Mater Med. 2000;11(6):393-7doi: 10.1023/a:1008990109419.
Andreopoulos, A. G., Hatzi, E. C., & Doxastakis, M. (2000). Controlled release systems based on poly(lactic acid). An in vitro and in vivo study. Journal of materials science. Materials in medicine, 11(6), 393-7. https://doi.org/10.1023/a:1008990109419
Andreopoulos, A G, et al. "Controlled release systems based on poly(lactic acid). An in vitro and in vivo study." Journal of materials science. Materials in medicine vol. 11,6 (2000): 393-7. doi: https://doi.org/10.1023/a:1008990109419
Andreopoulos AG, Hatzi EC, Doxastakis M. Controlled release systems based on poly(lactic acid). An in vitro and in vivo study. J Mater Sci Mater Med. 2000 Jun;11(6):393-7. doi: 10.1023/a:1008990109419. PMID: 15348021.
Copy Download .nbib Format: NLM
Acid-base equilibria in substituted 4-quinolone carboxylic acid solutions.

Talanta

Jelikic M, Veselinovic D, Djurdjevic P.
PMID: 18965434
Talanta. 1992 Jun;39(6):665-70. doi: 10.1016/0039-9140(92)80078-r.

The protonation constants of some substituted 4-quinolone carboxylic acid anions (ofloxacin, pefloxacin and ciprofloxacin) were determined in lithium chloride solution of various concentrations at 293, 303 and 313 K using the pH-metric and spectrophotometric methods. The values of thermodynamic...

Cite
Jelikic M, Veselinovic D, Djurdjevic P. Acid-base equilibria in substituted 4-quinolone carboxylic acid solutions. Talanta. 1992;39(6):665-70doi: 10.1016/0039-9140(92)80078-r.
Jelikic, M., Veselinovic, D., & Djurdjevic, P. (1992). Acid-base equilibria in substituted 4-quinolone carboxylic acid solutions. Talanta, 39(6), 665-70. https://doi.org/10.1016/0039-9140(92)80078-r
Jelikic, M, et al. "Acid-base equilibria in substituted 4-quinolone carboxylic acid solutions." Talanta vol. 39,6 (1992): 665-70. doi: https://doi.org/10.1016/0039-9140(92)80078-r
Jelikic M, Veselinovic D, Djurdjevic P. Acid-base equilibria in substituted 4-quinolone carboxylic acid solutions. Talanta. 1992 Jun;39(6):665-70. doi: 10.1016/0039-9140(92)80078-r. PMID: 18965434.
Copy Download .nbib Format: NLM
Quinolone pharmacokinetics.

International journal of antimicrobial agents

Robson RA.
PMID: 18611512
Int J Antimicrob Agents. 1992 Dec;2(1):3-10. doi: 10.1016/0924-8579(92)90020-r.

Fluoroquinolones have broad antibacterial spectra and are active against most Gram-negative and many Gram-positive species. They exhibit excellent oral bioavailability, extensive tissue penetration, low protein binding, and a long elimination half-life. This review compares and contrasts the pharmakonetics of...

Cite
Robson RA. Quinolone pharmacokinetics. Int J Antimicrob Agents. 1992;2(1):3-10doi: 10.1016/0924-8579(92)90020-r.
Robson, R. A. (1992). Quinolone pharmacokinetics. International journal of antimicrobial agents, 2(1), 3-10. https://doi.org/10.1016/0924-8579(92)90020-r
Robson, R A. "Quinolone pharmacokinetics." International journal of antimicrobial agents vol. 2,1 (1992): 3-10. doi: https://doi.org/10.1016/0924-8579(92)90020-r
Robson RA. Quinolone pharmacokinetics. Int J Antimicrob Agents. 1992 Dec;2(1):3-10. doi: 10.1016/0924-8579(92)90020-r. PMID: 18611512.
Copy Download .nbib Format: NLM
1-Ethyl-6-fluoro-7-(4-methyl-piperazin-4-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate hexa-hydrate.

Acta crystallographica. Section E, Structure reports online

An Z, Liang QC.
PMID: 21201468
Acta Crystallogr Sect E Struct Rep Online. 2008 Jan 16;64:o441. doi: 10.1107/S1600536808000421.

In the title compound, C(17)H(20)FN(3)O(3)·6H(2)O, the pefloxacin (pef) neutral zwitterion is accompanied by six water mol-ecules of hydration. An extensive network of O-H⋯O and N-H⋯O hydrogen bonds help to establish the crystal packing.

Cite
An Z, Liang QC. 1-Ethyl-6-fluoro-7-(4-methyl-piperazin-4-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate hexa-hydrate. Acta Crystallogr Sect E Struct Rep Online. 2008;64:o441doi: 10.1107/S1600536808000421.
An, Z., & Liang, Q. C. (2008). 1-Ethyl-6-fluoro-7-(4-methyl-piperazin-4-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate hexa-hydrate. Acta crystallographica. Section E, Structure reports online, 64o441. https://doi.org/10.1107/S1600536808000421
An, Zhe, and Liang, Qing-Cheng. "1-Ethyl-6-fluoro-7-(4-methyl-piperazin-4-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate hexa-hydrate." Acta crystallographica. Section E, Structure reports online vol. 64 (2008): o441. doi: https://doi.org/10.1107/S1600536808000421
An Z, Liang QC. 1-Ethyl-6-fluoro-7-(4-methyl-piperazin-4-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate hexa-hydrate. Acta Crystallogr Sect E Struct Rep Online. 2008 Jan 16;64:o441. doi: 10.1107/S1600536808000421. PMID: 21201468; PMCID: PMC2960169.
Copy Download .nbib Format: NLM
Tetra-kis(dihydrogen pefloxacinium) di-μ(2)-chlorido-bis-[tetra-chloridobismuthate(III)] tetra-chloride octa-hydrate.

Acta crystallographica. Section E, Structure reports online

Polishchuk AV, Gerasimenko AV, Gayvoronskaya KA, Karaseva ET.
PMID: 21202786
Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 19;64:m931-2. doi: 10.1107/S1600536808017674.

The title compound {systematic name: tetra-kis[4-(3-carb-oxy-1-ethyl-6-fluoro-4-hydroxonio-1,4-dihydro-7-quinol-yl)-1-meth-yl-piperazin-1-ium] di-μ(2)-chlorido-bis-[tetra-chlorido-bismuth-ate(III)] tetra-chloride octa-hydrate}, (C(17)H(22)FN(3)O(3))(4)[Bi(2)Cl(10)]Cl(4)·8H(2)O, is composed of edge-shared centrosymmetric dinuclear [Bi(2)Cl(10)](4-) anions, Cl(-) anions, dihydrogen pefloxacinium cations and water mol-ecules. The Bi(III) coordination polyhedron is a distorted octa-hedron. There are four short terminal...

Cite
Polishchuk AV, Gerasimenko AV, Gayvoronskaya KA, et al. Tetra-kis(dihydrogen pefloxacinium) di-μ(2)-chlorido-bis-[tetra-chloridobismuthate(III)] tetra-chloride octa-hydrate. Acta Crystallogr Sect E Struct Rep Online. 2008;64:m931-2doi: 10.1107/S1600536808017674.
Polishchuk, A. V., Gerasimenko, A. V., Gayvoronskaya, K. A., & Karaseva, E. T. (2008). Tetra-kis(dihydrogen pefloxacinium) di-μ(2)-chlorido-bis-[tetra-chloridobismuthate(III)] tetra-chloride octa-hydrate. Acta crystallographica. Section E, Structure reports online, 64m931-2. https://doi.org/10.1107/S1600536808017674
Polishchuk, A V, et al. "Tetra-kis(dihydrogen pefloxacinium) di-μ(2)-chlorido-bis-[tetra-chloridobismuthate(III)] tetra-chloride octa-hydrate." Acta crystallographica. Section E, Structure reports online vol. 64 (2008): m931-2. doi: https://doi.org/10.1107/S1600536808017674
Polishchuk AV, Gerasimenko AV, Gayvoronskaya KA, Karaseva ET. Tetra-kis(dihydrogen pefloxacinium) di-μ(2)-chlorido-bis-[tetra-chloridobismuthate(III)] tetra-chloride octa-hydrate. Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 19;64:m931-2. doi: 10.1107/S1600536808017674. PMID: 21202786; PMCID: PMC2961801.
Copy Download .nbib Format: NLM
Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria.

Infection and drug resistance

Olowe OA, Kukoyi OO, Taiwo SS, Ojurongbe O, Opaleye OO, Bolaji OS, Adegoke AA, Makanjuola OB, Ogbolu DO, Alli OT.
PMID: 23990730
Infect Drug Resist. 2013 Aug 20;6:87-92. doi: 10.2147/IDR.S48809. eCollection 2013.

INTRODUCTION: The characteristics and antimicrobial resistance profiles of Staphylococcus aureus differs according to geographical regions and in relation to antibiotic usage. The aim of this study was to determine the biochemical characteristics of the prevalent S. aureus from Ekiti...

Cite
Olowe OA, Kukoyi OO, Taiwo SS, et al. Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria. Infect Drug Resist. 2013;6:87-92doi: 10.2147/IDR.S48809.
Olowe, O. A., Kukoyi, O. O., Taiwo, S. S., Ojurongbe, O., Opaleye, O. O., Bolaji, O. S., Adegoke, A. A., Makanjuola, O. B., Ogbolu, D. O., & Alli, O. T. (2013). Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria. Infection and drug resistance, 687-92. https://doi.org/10.2147/IDR.S48809
Olowe, Olugbenga Adekunle, et al. "Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria." Infection and drug resistance vol. 6 (2013): 87-92. doi: https://doi.org/10.2147/IDR.S48809
Olowe OA, Kukoyi OO, Taiwo SS, Ojurongbe O, Opaleye OO, Bolaji OS, Adegoke AA, Makanjuola OB, Ogbolu DO, Alli OT. Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria. Infect Drug Resist. 2013 Aug 20;6:87-92. doi: 10.2147/IDR.S48809. eCollection 2013. PMID: 23990730; PMCID: PMC3753063.
Copy Download .nbib Format: NLM
Preparation and performance analysis of monodisperse glycidyl methacrylate modified restricted access media-imprinted materials.

Journal of separation science

Liu X, Pu J, Li J, Gong B.
PMID: 34933417
J Sep Sci. 2021 Dec 21; doi: 10.1002/jssc.202100746. Epub 2021 Dec 21.

Using monodisperse poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate) as the matrix, and pefloxacin template molecules, a novel restricted-access medium molecularly imprinted polymers with Bovine serum albumin crosslinked on its surface was prepared through reversible addition-fragmentation chain-transfer polymerization. Then, the obtained material...

Cite
Liu X, Pu J, Li J, et al. Preparation and performance analysis of monodisperse glycidyl methacrylate modified restricted access media-imprinted materials. J Sep Sci. 2021;doi: 10.1002/jssc.202100746.
Liu, X., Pu, J., Li, J., & Gong, B. (2021). Preparation and performance analysis of monodisperse glycidyl methacrylate modified restricted access media-imprinted materials. Journal of separation science, . https://doi.org/10.1002/jssc.202100746
Liu, Xiu, et al. "Preparation and performance analysis of monodisperse glycidyl methacrylate modified restricted access media-imprinted materials." Journal of separation science vol. (2021). doi: https://doi.org/10.1002/jssc.202100746
Liu X, Pu J, Li J, Gong B. Preparation and performance analysis of monodisperse glycidyl methacrylate modified restricted access media-imprinted materials. J Sep Sci. 2021 Dec 21; doi: 10.1002/jssc.202100746. Epub 2021 Dec 21. PMID: 34933417.
Copy Download .nbib Format: NLM
Early bacterial and inflammatory responses to antibiotic therapy in a model of polymicrobial peritonitis in rats.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Montravers P, Mohler J, Maulin L, Carbon C.
PMID: 11864278
Clin Microbiol Infect. 1998 Feb;4(12):701-709. doi: 10.1111/j.1469-0691.1998.tb00655.x.

OBJECTIVE: To assess the consequences of different more or less selective treatments on the microbiological and inflammatory responses within the peritoneum. METHODS: The early effects of various antibiotic regimens were evaluated in a model of polymicrobial peritonitis with specifically...

Cite
Montravers P, Mohler J, Maulin L, et al. Early bacterial and inflammatory responses to antibiotic therapy in a model of polymicrobial peritonitis in rats. Clin Microbiol Infect. 1998;4(12):701-709doi: 10.1111/j.1469-0691.1998.tb00655.x.
Montravers, P., Mohler, J., Maulin, L., & Carbon, C. (1998). Early bacterial and inflammatory responses to antibiotic therapy in a model of polymicrobial peritonitis in rats. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 4(12), 701-709. https://doi.org/10.1111/j.1469-0691.1998.tb00655.x
Montravers, Philippe, et al. "Early bacterial and inflammatory responses to antibiotic therapy in a model of polymicrobial peritonitis in rats." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 4,12 (1998): 701-709. doi: https://doi.org/10.1111/j.1469-0691.1998.tb00655.x
Montravers P, Mohler J, Maulin L, Carbon C. Early bacterial and inflammatory responses to antibiotic therapy in a model of polymicrobial peritonitis in rats. Clin Microbiol Infect. 1998 Feb;4(12):701-709. doi: 10.1111/j.1469-0691.1998.tb00655.x. PMID: 11864278.
Copy Download .nbib Format: NLM
Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects.

Journal of clinical and diagnostic research : JCDR

Veeraraghavan B, Anandan S, Sethuvel DP, Ragupathi NK.
PMID: 27656439
J Clin Diagn Res. 2016 Aug;10(8):DL01-2. doi: 10.7860/JCDR/2016/17022.8306. Epub 2016 Aug 01.

No abstract available.

Cite
Veeraraghavan B, Anandan S, Sethuvel DP, et al. Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects. J Clin Diagn Res. 2016;10(8):DL01-2doi: 10.7860/JCDR/2016/17022.8306.
Veeraraghavan, B., Anandan, S., Sethuvel, D. P., & Ragupathi, N. K. (2016). Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects. Journal of clinical and diagnostic research : JCDR, 10(8), DL01-2. https://doi.org/10.7860/JCDR/2016/17022.8306
Veeraraghavan, Balaji, et al. "Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects." Journal of clinical and diagnostic research : JCDR vol. 10,8 (2016): DL01-2. doi: https://doi.org/10.7860/JCDR/2016/17022.8306
Veeraraghavan B, Anandan S, Sethuvel DP, Ragupathi NK. Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects. J Clin Diagn Res. 2016 Aug;10(8):DL01-2. doi: 10.7860/JCDR/2016/17022.8306. Epub 2016 Aug 01. PMID: 27656439; PMCID: PMC5028453.
Copy Download .nbib Format: NLM
Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens.

Frontiers in veterinary science

Martínez MA, Ares I, Rodríguez JL, Martínez M, Martínez-Larrañaga MR, Isea G, Anadón A.
PMID: 28596959
Front Vet Sci. 2017 May 24;4:77. doi: 10.3389/fvets.2017.00077. eCollection 2017.

The pharmacokinetics of pefloxacin after single 10 mg/kg BW intravenous (IV) and oral doses were studied in healthy broiler chickens. For 24 h, serial blood samples were obtained after IV and oral administration. Concentrations of pefloxacin and its major...

Cite
Martínez MA, Ares I, Rodríguez JL, et al. Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens. Front Vet Sci. 2017;4:77doi: 10.3389/fvets.2017.00077.
Martínez, M. A., Ares, I., Rodríguez, J. L., Martínez, M., Martínez-Larrañaga, M. R., Isea, G., & Anadón, A. (2017). Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens. Frontiers in veterinary science, 477. https://doi.org/10.3389/fvets.2017.00077
Martínez, María-Aránzazu, et al. "Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens." Frontiers in veterinary science vol. 4 (2017): 77. doi: https://doi.org/10.3389/fvets.2017.00077
Martínez MA, Ares I, Rodríguez JL, Martínez M, Martínez-Larrañaga MR, Isea G, Anadón A. Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens. Front Vet Sci. 2017 May 24;4:77. doi: 10.3389/fvets.2017.00077. eCollection 2017. PMID: 28596959; PMCID: PMC5442175.
Copy Download .nbib Format: NLM
Effects of fluoroquinolones and glucocorticoids on cultivated tendon cells in vitro.

Toxicology in vitro : an international journal published in association with BIBRA

Kempka G, Ahr HJ, Rüther W, Schlüter G.
PMID: 20650258
Toxicol In Vitro. 1996 Dec;10(6):743-54. doi: 10.1016/s0887-2333(96)00050-1.

Achilles tendon rupture is known to occur after administration of various drugs to patients. It is also reported to occur after treatment with fluoroquinolone and glucocorticoids. To study potential cytotoxic effects of fluoroquinolones (ciprofloxacin, pefloxacin, sparfloxacin) and triamcinolonacetonide on...

Cite
Kempka G, Ahr HJ, Rüther W, et al. Effects of fluoroquinolones and glucocorticoids on cultivated tendon cells in vitro. Toxicol In Vitro. 1996;10(6):743-54doi: 10.1016/s0887-2333(96)00050-1.
Kempka, G., Ahr, H. J., Rüther, W., & Schlüter, G. (1996). Effects of fluoroquinolones and glucocorticoids on cultivated tendon cells in vitro. Toxicology in vitro : an international journal published in association with BIBRA, 10(6), 743-54. https://doi.org/10.1016/s0887-2333(96)00050-1
Kempka, G, et al. "Effects of fluoroquinolones and glucocorticoids on cultivated tendon cells in vitro." Toxicology in vitro : an international journal published in association with BIBRA vol. 10,6 (1996): 743-54. doi: https://doi.org/10.1016/s0887-2333(96)00050-1
Kempka G, Ahr HJ, Rüther W, Schlüter G. Effects of fluoroquinolones and glucocorticoids on cultivated tendon cells in vitro. Toxicol In Vitro. 1996 Dec;10(6):743-54. doi: 10.1016/s0887-2333(96)00050-1. PMID: 20650258.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 46 entries